Usted buscó: cyclosphosphamide (Maltés - Inglés)

fl-adulti busulfan fresenius kabi jintuża flimkien ma’ cyclosphosphamide jew fludarabine.
in adults busulfan fresenius kabi is used in combination with cyclophosphamide or fludarabine.

1060 pazjent ġew magħżula b’mod arbitrarju biex jirċievu jew docetaxel 75 mg/m2 mogħti siegħa wara doxorubicin 50 mg/m2 u cyclophosphamide 500 mg/m2 (539 pazjent fil-fergħa tat-tac ), jew doxorubicin 50 mg/m2 segwit minn fluorouracil 500 mg/m2 u cyclosphosphamide 500 mg/m2 (521 pazjent fil-fergħa tal-fac ), bħala kura miżjuda f’pazjenti b’kanċer operabbli fis-sider li ma nfirixx fil-glandoli limfatiċi tas-sider u li għandhom riskju għoli ta’ rikaduta skont il-kriterji st.gallen tal- 1998 (daqs tat-tumur >2 cm u/jew re u rp negattivi u/jew grad għoli istoloġiku/nukleari (grad 2 sa 3) u /jew età <35 sena).
1060 patients were randomized to receive either docetaxel 75 mg/m2 administered 1-hour after doxorubicin 50 mg/m2 and cyclophosphamide 500 mg/m2 (539 patients in tac arm), or doxorubicin 50 mg/m2 followed by fluorouracil 500 mg/m2 and cyclosphosphamide 500 mg/m2 (521 patients in fac arm), as adjuvant treatment of operable node-negative breast cancer patients with high risk of relapse according to 1998 st. gallen criteria (tumour size >2 cm and/or negative er and pr and/or high histological/nuclear grade (grade 2 to 3) and /or age <35 years).).